BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29486915)

  • 21. In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus.
    Wang F; Tasset I; Cuervo AM; Muller S
    Cells; 2020 Oct; 9(10):. PubMed ID: 33092174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice.
    Jabs DA; Gérard HC; Wei Y; Campbell AL; Hudson AP; Akpek EK; Lee B; Prendergast RA; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2293-8. PubMed ID: 15223808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB.
    Saito K; Mori S; Date F; Hong G
    Autoimmunity; 2015; 48(6):379-88. PubMed ID: 25847253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dry eye management in a Sjögren's syndrome mouse model by inhibition of p38-MAPK pathway.
    Ma X; Zou J; He L; Zhang Y
    Diagn Pathol; 2014 Jan; 9():5. PubMed ID: 24443980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice.
    Yanagi K; Haneji N; Hamano H; Takahashi M; Higashiyama H; Hayashi Y
    Cell Immunol; 1996 Mar; 168(2):243-50. PubMed ID: 8640871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide.
    Macri C; Wang F; Tasset I; Schall N; Page N; Briand JP; Cuervo AM; Muller S
    Autophagy; 2015; 11(3):472-86. PubMed ID: 25719862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome.
    Sullivan DA; Edwards JA
    J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):237-45. PubMed ID: 9191982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Akpek EK; Jabs DA; Gérard HC; Prendergast RA; Hudson AP; Lee B; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):185-90. PubMed ID: 14691172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructural study of Sjögren's syndrome-like disease in MRL/l mice.
    Tanaka A; O'Sullivan FX; Koopman WJ; Gay S
    J Oral Pathol; 1988 Nov; 17(9-10):460-5. PubMed ID: 3150433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome.
    Aluri HS; Kublin CL; Thotakura S; Armaos H; Samizadeh M; Hawley D; Thomas WM; Leavis P; Makarenkova HP; Zoukhri D
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5218-28. PubMed ID: 26244298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
    Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
    Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of caspase cascade on the development of primary Sjögren's syndrome.
    Hayashi Y; Arakaki R; Ishimaru N
    J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine cytomegalovirus induces a Sjögren's syndrome-like disease in C57Bl/6-lpr/lpr mice.
    Fleck M; Kern ER; Zhou T; Lang B; Mountz JD
    Arthritis Rheum; 1998 Dec; 41(12):2175-84. PubMed ID: 9870874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of sialadenitis after cellular transfer in autoimmune MRL/lpr mice.
    Skarstein K; Johannessen AC; Holmdahl R; Jonsson R
    Clin Immunol Immunopathol; 1997 Aug; 84(2):177-84. PubMed ID: 9245550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL/Mp-lpr/lpr mouse model of Sjögren's syndrome.
    Ono M; Rocha FJ; Sullivan DA
    Exp Eye Res; 1995 Dec; 61(6):659-66. PubMed ID: 8846837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of Sjögren's syndrome.
    Mavragani CP; Moutsopoulos NM; Moutsopoulos HM
    Nat Clin Pract Rheumatol; 2006 May; 2(5):252-61. PubMed ID: 16932698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome.
    Scofield RH; Asfa S; Obeso D; Jonsson R; Kurien BT
    J Immunol; 2005 Dec; 175(12):8409-14. PubMed ID: 16339583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lacrimation and salivation are not related to lymphocytic infiltration in lacrimal and salivary glands in MRL lpr/lpr mice.
    Fujita H; Fujihara T; Takeuchi T; Saito I; Tsubota K
    Adv Exp Med Biol; 1998; 438():941-8. PubMed ID: 9634991
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of androgen therapy in Sjögren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice.
    Sato EH; Ariga H; Sullivan DA
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2537-45. PubMed ID: 1634351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus.
    Page N; Gros F; Schall N; Décossas M; Bagnard D; Briand JP; Muller S
    Ann Rheum Dis; 2011 May; 70(5):837-43. PubMed ID: 21173017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.